Multimodality imaging of malignant pheochromocytoma

Clinical Nuclear Medicine

Volumn 31, Issue 12, 2006, Pages 822-825

  Esfandiari, Nazanene H ^a   Shulkin, Barry L ^b,c   Bui, Chuong ^b   Jaffe, Craig A ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^c ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

Epinephrine; FDG; In 111 pentetreotide; MIBG; PET; Pheochromocytoma

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123; ADRENALIN; CARBON 11; CATECHOLAMINE; FLUORODEOXYGLUCOSE F 18; NORADRENALIN TRANSPORTER; OCTREOTIDE; PENTETREOTIDE IN 111; SOMATOSTATIN DERIVATIVE; SOMATOSTATIN RECEPTOR; TRACER;

ADRENALECTOMY; ADULT; ARTICLE; ASPIRATION BIOPSY; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONGESTIVE HEART FAILURE; DEATH; DYSPNEA; HUMAN; HYPERTENSION; IMAGING; MALE; PHEOCHROMOCYTOMA; POSITRON EMISSION TOMOGRAPHY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TUMOR LOCALIZATION;

ADRENAL GLAND NEOPLASMS; FLUORODEOXYGLUCOSE F18; HUMANS; IMAGE ENHANCEMENT; INDIUM RADIOISOTOPES; MALE; MIDDLE AGED; PHEOCHROMOCYTOMA; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 33751203234     PISSN: 03639762     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.rlu.0000247734.67566.0a     Document Type: Article

References (10)

1. Bravo EL. Evolving concepts in the pathophysiology, diagnosis, and treatment of pheochromocytoma. Endocrine Rev. 1994;15:356-368.
2. Lenders JWM, Pacak K, Walther MM, et al. Biochemical diagnosis of pheochromocytoma. Which test is best? JAMA. 2002;287:1427-1434.
3. Witteles RM, Kaplan EL, Roizen MF. Sensitivity of diagnostic and localization tests for pheochromocytoma in clinical practice. Arch Intern Med. 2000;160:2521-2524.
4. Shulkin BL, Shapiro B, Francis IR, et al. Primary extra-adrenal pheochromocytoma: Positive I-123 MIBG imaging with negative I-131 MIBG imaging. Clin Nucl Med. 1986;11:851-854.
5. van der Harst E, de Herder WW, Bruining HA, et al. [(123)I] metaiodobenzylguanidine and [(111)In]octreotide uptake in benign and malignant pheochromocytomas. J Clin Endocrinol Metab. 2001;86:685-693.
6. Tenenbaum F, Lumbroso J, Schlumberger M, et al. Comparison of radiolabeled octreotide and meta-iodobenzylguanidine (MIBG) scintigraphy in malignant pheochromocytoma. J Nucl Med. 1995;36:1-6.
7. Kwekkeboom DJ, Mueller-Brand J, Paganelli G, et al. Overview of results of peptide receptor radionuclide therapy with 3 radiolabeled somatostatin analogs. J Nucl Med. 2005;46(suppl 1):62S-66S.
8. Bushnell D, O'Dorisio T, Menda Y, et al. Evaluating the clinical effectiveness of 90Y-SMT 487 in patients with neuroendocrine tumors. J Nucl Med. 2003;44:1556-1560.
9. Shulkin BL, Wieland DM, Sisson JC. PET studies of pheochromocytoma with C-11 epinephrine. Radiology. 1994;193:273.
10. Shulkin BL, Thompson NW, Shapiro B, et al. Pheochromocytomas: imaging with 2-(fluorine-18)fluoro-2-deoxy-D-glucose PET. Radiology. 1999;212:35-41.